Sakamoto Jun, Ogura Takeshi, Ueno Saori, Okuda Atsushi, Nishioka Nobu, Hakoda Akitoshi, Uba Yuki, Tomita Mitsuki, Hattori Nobuhiro, Nakamura Junichi, Bessho Kimi, Nishikawa Hiroki
2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki-shi, Japan.
2nd Department of Internal Medicine, Osaka Medical College, Takatsuki-shi, Japan.
Endosc Int Open. 2024 Feb 28;12(2):E262-E268. doi: 10.1055/a-2261-3137. eCollection 2024 Feb.
Biloma is treated endoscopically with endoscopic retrograde cholangiography (ERCP) or endoscopi ultrasound-guided transluminal biloma drainage (EUS-TBD). However, almost all previous studies have used both internal and external drainage. External drainage has the disadvantages of poor cosmetic appearance and self-tube removal. The aim of the present study was to evaluate the internal endoscopic drainage for complex biloma after hepatobiliary surgery with an ERCP- or EUS-guided approach, without external drainage. This retrospective study included consecutive patients who had bilomas. A 7F plastic stent was deployed from the biloma to the duodenum in the ERCP group and the metal stent was deployed from the biloma to the stomach in the EUS-TBD group. Forty-seven patients were enrolled. The technical success rate was similar between the groups (ERCP 94% vs EUS-TBD 100%, =0.371); however, mean procedure time was significantly shorter in the EUS-TBD group (16.9 minutes) than in the ERCP group (26.6 minutes) ( =0.009). The clinical success rate was 87% (25 of 32 patients) in the ERCP group and 84% (11 of 13 patients) in the EUS-TBD group ( =0.482). The duration of median hospital stay was significantly shorter in the EUS-TBD group (22 days) than in the ERCP group (46 days) ( =0.038). There was no significant difference in procedure-associated adverse events between the groups. In conclusion, ERCP and EUS-TBD are complementary techniques, each with its own merits in specific clinical scenarios. If both techniques can be performed, EUS-TBD should be considered because of the short times for the procedure, hospital stay. and biloma resolution.
胆汁瘤可通过内镜逆行胆管造影术(ERCP)或内镜超声引导下经腔胆汁瘤引流术(EUS-TBD)进行内镜治疗。然而,几乎所有先前的研究都同时使用了内引流和外引流。外引流具有外观不佳和需要自行拔除引流管的缺点。本研究的目的是评估在ERCP或EUS引导下,不进行外引流的内镜下内引流治疗肝胆手术后复杂胆汁瘤的效果。这项回顾性研究纳入了患有胆汁瘤的连续患者。在ERCP组中,将一根7F塑料支架从胆汁瘤置入十二指肠,在EUS-TBD组中,将金属支架从胆汁瘤置入胃内。共纳入47例患者。两组的技术成功率相似(ERCP组为94%,EUS-TBD组为100%,P =0.371);然而,EUS-TBD组的平均手术时间(16.9分钟)明显短于ERCP组(26.6分钟)(P =0.009)。ERCP组的临床成功率为87%(32例患者中的25例),EUS-TBD组为84%(13例患者中的11例)(P =0.482)。EUS-TBD组的中位住院时间(22天)明显短于ERCP组(46天)(P =0.038)。两组之间与手术相关的不良事件无显著差异。总之,ERCP和EUS-TBD是互补技术,在特定临床场景中各有优点。如果两种技术都可行,由于手术时间、住院时间和胆汁瘤消退时间较短,应考虑选择EUS-TBD。